BLFS vs EOLS: fair value comparison
BioLife Solutions, Inc. and Evolus, Inc. · Updated 2026-10-19
BLFS's estimate rests on a sector-average multiple, which TickrTrends does not publish as a verdict. EOLS's estimate rests on a sector-average multiple, which TickrTrends does not publish as a verdict. Within Healthcare, EOLS currently ranks higher by quality score.
| BLFS | EOLS | |
|---|---|---|
| Verdict | Awaiting full valuation | Awaiting full valuation |
| Last price | $38.61 | $7.10 |
| 12-month range | $18.15–$39.22 | $3.94–$9.30 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #111 of 301 Healthcare | #109 of 301 Healthcare |
| Quality grade | C | C |
| Leverage | Low | Low |
| Margin trend | Contracting | Stable |
| Revenue growth | Modest | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | Mixed |
| 52-week position | The top quarter | The upper-middle quarter |
Full single-stock breakdowns: BLFS fair value analysis · EOLS fair value analysis